Anxiety symptoms can occur in up to 65% of patients with schizophrenia, and may reach the
threshold for diagnosis of various comorbid anxiety disorders, including obsessive …

This narrative review gathers together a range of international experts to critically appraise
the existing trial-based evidence relating to the efficacy and tolerability of pharmacotherapy …

Abstract Purpose of Review This review will aim to summarize the current body of
epidemiological, clinical and therapeutic knowledge concerning specific co-occurrence of …

Abstract Obsessive Compulsive Disorder (OCD) and Obsessive Compulsive Symptoms
(OCS) are known to be highly comorbid with bipolar disorder and schizophrenia. Comorbid …

The presence of obsessive-compulsive symptoms (OCS) and obsessive-compulsive
disorders (OCD) in schizophrenia is frequent, and a new clinical entity has been proposed …

Overwhelming research evidence suggests that the negative symptoms of schizophrenia
(NSS) contribute more to impaired quality of life and poor functioning than positive …

Schizophrenia (SCZ) is a severe mental illness mainly characterized by a number of
psychiatric symptoms. Obsessive–compulsive disorder (OCD) is a long-lasting and …

The prevalence of OCS and OCD is higher in schizophrenic patients than in the general
population. These disorders are sometimes induced by AAPs. There is higher frequency of …

Obsessive-compulsive disorder is often associated with schizophrenia and may represent a
significant challenge in the treatment as this comorbidity may not respond properly to …

The present study aims to discuss the effect of escitalopram in glial cell line-derived
neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF) levels, and 5 …